Hyperosmolarity drives hypertension and CKD-water and salt revisited

Nature Reviews Nephrology

Volumn 10, Issue 7, 2014, Pages 415-420

  Johnson, Richard J ^a   Rodriguez Iturbe, Bernardo ^b   Roncal Jimenez, Carlos ^c   Lanaspa, Miguel A ^c   Ishimoto, Takuji ^c   Nakagawa, Takahiko ^d   Correa Rotter, Ricardo ^e   Wesseling, Catharina ^f   Bankir, Lise ^g   Sanchez Lozada, Laura G ^h  

^a Research Geriatrics Ambulatory Care and Cardiology Veterans Affairs Eastern Colorado Health Care System   (United States)

^b UNIVERSIDAD DEL ZULIA   (Venezuela)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^d KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^f UNIVERSIDAD NACIONAL   (Costa Rica)

^g CENTRE DE RECHERCHE DES CORDELIERS   (France)

^h Laboratory of Renal Physiopathology and Department of Nephrology   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

FRUCTOSE; SODIUM CHLORIDE; SUGAR; VASOPRESSIN; WATER;

CHRONIC KIDNEY DISEASE; DEHYDRATION; FLUID INTAKE; HYPEROSMOLARITY; HYPERTENSION; INFLAMMATION; KIDNEY INJURY; PRIORITY JOURNAL; REVIEW; SODIUM DEPLETION;

AGRICULTURAL WORKERS' DISEASES; CENTRAL AMERICA; DEHYDRATION; FRUCTOKINASES; HUMANS; HYPERTENSION; KIDNEY DISEASES; OSMOLAR CONCENTRATION; PLASMA; RENAL INSUFFICIENCY, CHRONIC;

EID: 84903528840     PISSN: 17595061     EISSN: 1759507X     Source Type: Journal    
DOI: 10.1038/nrneph.2014.76     Document Type: Review

References (83)

1. Torres, C. et al. Decreased kidney function of unknown cause in Nicaragua: a community-based survey. Am. J. Kidney Dis. 55, 485-496 (2010).
2. Weiner, D. E., McClean, M. D., Kaufman, J. S. & Brooks, D. R. The Central American epidemic of CKD. Clin. J. Am. Soc. Nephrol. 8, 504-511 (2013).
3. Wesseling, C. et al. Resolving the enigma of the Mesoamerican nephropathy: a research workshop summary. Am. J. Kidney Dis. 63, 396-404 (2013).
4. Correa-Rotter, R., Wesseling, C. & Johnson, R. J. Chronic kidney disease of unknown origin in Central America: the case for a Mesoamerican nephropathy. Am. J. Kidney Dis. 63, 506-520 (2014).
5. O'Donnell, J. K. et al. Prevalence of and risk factors for chronic kidney disease in rural Nicaragua. Nephrol. Dial Transplant 26, 2798-2805 (2011).
6. Wijkstrom, J. et al. Clinical and pathological characterization of mesoamerican nephropathy: a new kidney disease in Central America. Am. J. Kidney Dis. 62, 908-918 (2013).
7. Dominguez, J., Moya Perez, C. & Jansa, J. M. Análisis de Prevalencia y Determinantes de la Insuficiencia Renal Crónica en la costa del Océano Pacífico: Sur de México, Guatemala, El Salvador y Honduras [Spanish]. (Agencia Municipal de Salut Pública, 2003).
8. Garcia Trabiano, R. Nefropatía terminal en pacientes de un hospital de referencia en El Salvador [Spanish]. Rev. Panam. Salud Publica 12, 202-206 (2002).
9. Peraza, S. et al. Decreased kidney function among agricultural workers in El Salvador. Am. J. Kidney Dis. 59, 531-540 (2012).
10. Solis, G. in Impacto de las medidas preventivas para evitar el deterioro de la función renal por el Síndrome de Golpe por Calor en trabajadores agrícolas del Ingenio San Antonio del Occidente de Nicaragua, Ciclo Agrícola 2005-2006 [Spanish]. Thesis, Universidad Nacional Autonoma de Nicaragua (2007).
11. Roncal Jimenez, C. A. et al. Fructokinase activity mediates dehydration-induced renal injury. Kidney Int. http://dx.doi.org/10.1038/ki.2013. 492 (2013).
12. Nanayakkara, S. et al. Tubulointerstitial damage as the major pathological lesion in endemic chronic kidney disease among farmers in North Central Province of Sri Lanka. Environ. Health Prev. Med. 17, 213-221 (2012).
13. Schrier, R. W., Henderson, H. S., Tisher, C. C. & Tannen, R. L. Nephropathy associated with heat stress and exercise. Ann. Intern. Med. 67, 356-376 (1967).
14. Crowe, J. et al. Heat exposure in sugarcane harvesters in Costa Rica. Am. J. Ind. Med. 56, 1157-1164 (2013).
15. Bankir, L., Bouby, N. & Ritz, E. Vasopressin: a novel target for the prevention and retardation of kidney disease? Nat. Rev. Nephrol 9, 223-239 (2013).
16. Bankir, L., Bichet, D. G. & Bouby, N. Vasopressin V2 receptors, ENaC, and sodium reabsorption: a risk factor for hypertension? Am. J. Physiol. Renal Physiol. 299, F917-F928 (2010).
17. Bardoux, P. et al. Vasopressin increases urinary albumin excretion in rats and humans: involvement of V2 receptors and the renin-angiotensin system. Nephrol. Dial. Transplant. 18, 497-506 (2003). (Pubitemid 36305653)
18. Bardoux, P. et al. Vasopressin contributes to hyperfiltration, albuminuria, and renal hypertrophy in diabetes mellitus: study in vasopressin-deficient Brattleboro rats. Proc. Natl Acad. Sci. USA 96, 10397-10402 (1999). (Pubitemid 29422569)
19. Burg, M. B. Molecular basis of osmotic regulation. Am. J. Physiol. 268, F983-F996 (1995).
20. Schmolke, M., Schilling, A., Keiditsch, E. & Guder, W. G. Intrarenal distribution of organic osmolytes in human kidney. Eur. J. Clin. Chem. Clin. Biochem. 34, 499-501 (1996). (Pubitemid 26232362)
21. Bouby, N., Bachmann, S., Bichet, D. & Bankir, L. Effect of water intake on the progression of chronic renal failure in the 5/6 nephrectomized rat. Am. J. Physiol. 258, F973-F979 (1990). (Pubitemid 20155510)
22. Bardoux, P., Bruneval, P., Heudes, D., Bouby, N. & Bankir, L. Diabetes-induced albuminuria: role of antidiuretic hormone as revealed by chronic V2 receptor antagonism in rats. Nephrol. Dial. Transplant. 18, 1755-1763 (2003). (Pubitemid 37098545)
23. Bouby, N. et al. Vasopressin increases glomerular filtration rate in conscious rats through its antidiuretic action. J. Am. Soc. Nephrol. 7, 842-851 (1996). (Pubitemid 27465977)
24. Schrier, R. W., Harris, D. C., Chan, L., Shapiro, J. I. & Caramelo, C. Tubular hypermetabolism as a factor in the progression of chronic renal failure. Am. J. Kidney Dis. 12, 243-249 (1988).
25. Lehninger, A. L. & Neubert, D. Effect of oxytocin, vasopressin, and other disulfide hormones on uptake and extrusion of water by mitochondria. Proc. Natl Acad. Sci. USA 47, 1929-1936 (1961).
26. Assimacopoulos-Jeannet, F., McCormack, J. G. & Jeanrenaud, B. Vasopressin and/or glucagon rapidly increases mitochondrial calcium and oxidative enzyme activities in the perfused rat liver. J. Biol. Chem. 261, 8799-8804 (1986). (Pubitemid 17205078)
27. Bolignano, D. & Zoccali, C. Vasopressin beyond water: implications for renal diseases. Curr. Opin. Nephrol. Hypertens. 19, 499-504 (2010).
28. Burger-Kentischer, A. et al. Hypertonicity-induced accumulation of organic osmolytes in papillary interstitial cells. Kidney Int. 55, 1417-1425 (1999). (Pubitemid 29157140)
29. Diggle, C. P. et al. Both isoforms of ketohexokinase are dispensable for normal growth and development. Physiol. Genomics 42A, 235-243 (2010).
30. Cirillo, P. et al. Ketohexokinase-dependent metabolism of fructose induces proinflammatory mediators in proximal tubular cells. J. Am. Soc. Nephrol. 20, 545-553 (2009).
31. Ishimoto, T. et al. Opposing effects of fructokinase C and A isoforms on fructose-induced metabolic syndrome in mice. Proc. Natl Acad. Sci. USA 109, 4320-4325 (2012).
32. Bergheim, I. et al. Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin. J. Hepatol. 48, 983-992 (2008).
33. Johnson, R. J. et al. Fructokinase, fructans, intestinal permeability, and metabolic syndrome: an equine connection? J. Equine Vet. Sci. 33, 120-126 (2013).
34. Ishimoto, T. et al. High fat and high sucrose (western) diet induce steatohepatitis that is dependent on fructokinase. Hepatology 58, 1632-1643 (2013).
35. Diggle, C. P. et al. Ketohexokinase: expression and localization of the principal fructose-metabolizing enzyme. J. Histochem. Cytochem. 57, 763-774 (2009).
36. Nakayama, T. et al. Dietary fructose causes tubulointerstitial injury in the normal rat kidney. Am. J. Physiol. Renal Physiol. 298, F712-F720 (2010).
37. Johner, S. A. et al. Urinary fructose: a potential biomarker for dietary fructose intake in children. Eur. J. Clin. Nutr. 64, 1365-1370 (2010).
38. Luceri, C. et al. Urinary excretion of sucrose and fructose as a predictor of sucrose intake in dietary intervention studies. Cancer Epidemiol. Biomarkers Prev. 5, 167-171 (1996).
39. Aoyama, M. et al. Fructose induces tubulointerstitial injury in the kidney of mice. Biochem. Biophys. Res. Commun. 419, 244-249 (2012).
40. Gersch, M. S. et al. Fructose, but not dextrose, accelerates the progression of chronic kidney disease. Am. J. Physiol. Renal Physiol. 293, F1256-F1261 (2007). (Pubitemid 47583960)
41. Ko, B. C., Ruepp, B., Bohren, K. M., Gabbay, K. H. & Chung, S. S. Identification and characterization of multiple osmotic response sequences in the human aldose reductase gene. J. Biol. Chem. 272, 16431-16437 (1997). (Pubitemid 27276469)
42. Lanaspa, M. A. et al. Endogenous fructose production and fructokinase activation mediate renal injury in diabetic nephropathy. J. Am. Soc. Nephrol. (in press).
43. de Wardener, H. E., He, F. J. & MacGregor, G. A. Plasma sodium and hypertension. Kidney Int. 66, 2454-2466 (2004).
44. Imig, J. D. & Ryan, M. J. Immune and inflammatory role in renal disease. Compr. Physiol. 3, 957-976 (2013).
45. Shapiro, L. & Dinarello, C. A. Osmotic regulation of cytokine synthesis in vitro. Proc. Natl Acad. Sci. USA 92, 12230-12234 (1995). (Pubitemid 26014044)
46. Shapiro, L. & Dinarello, C. A. Hyperosmotic stress as a stimulant for proinflammatory cytokine production. Exp. Cell Res. 231, 354-362 (1997). (Pubitemid 27187988)
47. Ying, W. Z. & Sanders, P. W. Dietary salt modulates renal production of transforming growth factor-β in rats. Am. J. Physiol. 274, F635-F641 (1998).
48. Gu, J. W. et al. Sodium induces hypertrophy of cultured myocardial myoblasts and vascular smooth muscle cells. Hypertension 31, 1083-1087 (1998).
49. Toney, G. M. & Stocker, S. D. Hyperosmotic activation of CNS sympathetic drive: implications for cardiovascular disease. J. Physiol. 588, 3375-3384 (2010).
50. Mathai, M. L., Evered, M. D. & McKinley, M. J. Central losartan blocks natriuretic, vasopressin, and pressor responses to central hypertonic NaCl in sheep. Am. J. Physiol. 275, R548-R554 (1998).
51. O'Donaughy, T. L. & Brooks, V. L. Deoxycorticosterone acetate-salt rats: hypertension and sympathoexcitation driven by increased NaCl levels. Hypertension 47, 680-685 (2006). (Pubitemid 43740238)
52. Friedman, S. M., McIndoe, R. A. & Tanaka, M. The relation of blood sodium concentration to blood pressure in the rat. J. Hypertens. 8, 61-66 (1990). (Pubitemid 20186315)
53. Suckling, R. J., He, F. J., Markandu, N. D. & MacGregor, G. A. Dietary salt influences postprandial plasma sodium concentration and systolic blood pressure. Kidney Int. 81, 407-411 (2012).
54. Dickinson, K. M., Clifton, P. M., Burrell, L. M., Barrett, P. H. & Keogh, J. B. Postprandial effects of a high salt meal on serum sodium, arterial stiffness, markers of nitric oxide production and markers of endothelial function. Atherosclerosis 232, 211-216 (2014).
55. Wenner, M. M., Rose, W. C., Delaney, E. P., Stillabower, M. E. & Farquhar, W. B. Influence of plasma osmolality on baroreflex control of sympathetic activity. Am. J. Physiol. Heart Circ. Physiol. 293, H2313-H2319 (2007). (Pubitemid 47605876)
56. Charkoudian, N., Eisenach, J. H., Joyner, M. J., Roberts, S. K. & Wick, D. E. Interactions of plasma osmolality with arterial and central venous pressures in control of sympathetic activity and heart rate in humans. Am. J. Physiol. Heart Circ. Physiol. 289, H2456-H2460 (2005). (Pubitemid 41698557)
57. 23Na magnetic resonance imaging of tissue sodium. Hypertension 59, 167-172 (2012).
58. Beduschi, G. C., Telini, L. S., Caramori, J. C., Martin, L. C. & Barretti, P. Effect of dialysate sodium reduction on body water volume, blood pressure, and inflammatory markers in hemodialysis patients-a prospective randomized controlled study. Ren. Fail. 35, 742-747 (2013).
59. Bourque, C. W. Central mechanisms of osmosensation and systemic osmoregulation. Nature Rev. Neurosci. 9, 519-531 (2008). (Pubitemid 351873462)
60. Lechner, S. G. et al. The molecular and cellular identity of peripheral osmoreceptors. Neuron 69, 332-344 (2011).
61. McMahon, E. J. et al. A randomized trial of dietary sodium restriction in CKD. J. Am. Soc. Nephrol. 24, 2096-2103 (2013).
62. Krikken, J. A., Laverman, G. D. & Navis, G. Benefits of dietary sodium restriction in the management of chronic kidney disease. Curr. Opin. Nephrol. Hypertens. 18, 531-538 (2009).
63. Lambers Heerspink, H. J., Navis, G. & Ritz, E. Salt intake in kidney disease-a missed therapeutic opportunity? Nephrol. Dial. Transplant. 27, 3435-3442 (2012).
64. Aaron, K. J. & Sanders, P. W. Role of dietary salt and potassium intake in cardiovascular health and disease: a review of the evidence. Mayo Clin. Proc. 88, 987-995 (2013).
65. Jones-Burton, C. et al. An in-depth review of the evidence linking dietary salt intake and progression of chronic kidney disease. Am. J. Nephrol. 26, 268-275 (2006). (Pubitemid 44114397)
66. Cook, N. R. et al. Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP). BMJ 334, 885-894 (2007).
67. Vegter, S. et al. Sodium intake, ACE inhibition, and progression to ESRD. J. Am. Soc. Nephrol. 23, 165-173 (2012).
68. Alderman, M. H., Madhavan, S., Cohen, H., Sealey, J. E. & Laragh, J. H. Low urinary sodium is associated with greater risk of myocardial infarction among treated hypertensive men. Hypertension 25, 1144-1152 (1995).
69. Ekinci, E. I. et al. Dietary salt intake and mortality in patients with type 2 diabetes. Diabetes Care 34, 703-709 (2011).
70. Thomas, M. C. et al. The association between dietary sodium intake, ESRD, and all-cause mortality in patients with type 1 diabetes. Diabetes Care 34, 861-866 (2011).
71. Clark, W. F. et al. Urine volume and change in estimated GFR in a community-based cohort study. Clin. J. Am. Soc. Nephrol. 6, 2634-2641 (2011).
72. Strippoli, G. F. et al. Fluid and nutrient intake and risk of chronic kidney disease. Nephrology 16, 326-334 (2011).
73. Sontrop, J. M. et al. Association between water intake, chronic kidney disease, and cardiovascular disease: a cross-sectional analysis of NHANES data. Am. J. Nephrol. 37, 434-442 (2013).
74. Palmer, S. C. et al. Fluid intake and all-cause mortality, cardiovascular mortality, and kidney function: a population-based longitudinal cohort study. Nephrol. Dial Transplant http://dx.doi.org/10.1093/ndt/gft507 (2014).
75. Hebert, L. A., Greene, T., Levey, A., Falkenhain, M. E. & Klahr, S. High urine volume and low urine osmolality are risk factors for faster progression of renal disease. Am. J. Kidney Dis. 41, 962-971 (2003). (Pubitemid 36532130)
76. McMahon, E. J., Campbell, K. L., Mudge, D. W. & Bauer, J. D. Achieving salt restriction in chronic kidney disease. Int. J. Nephrol. 2012, 720429 (2012).
77. Choukroun, G., Schmitt, F., Martinez, F., Drueke, T. B. & Bankir, L. Low urine flow reduces the capacity to excrete a sodium load in humans. Am. J. Physiol. 273, R1726-R1733 (1997). (Pubitemid 27518125)
78. Perucca, J., Bouby, N., Valeix, P. & Bankir, L. Sex difference in urine concentration across differing ages, sodium intake, and level of kidney disease. Am. J. Physiol. Regul. Integr. Comp. Physiol. 292, R700-R705 (2007). (Pubitemid 46207719)
79. Zerbe, R. L. & Robertson, G. L. Osmoregulation of thirst and vasopressin secretion in human subjects: effect of various solutes. Am. J. Physiol. 244, E607-E614 (1983). (Pubitemid 13067074)
80. Wolf, J. P., Nguyen, N. U., Dumoulin, G. & Berthelay, S. Influence of hypertonic monosaccharide infusions on the release of plasma arginine vasopressin in normal humans. Horm. Metab. Res. 24, 379-383 (1992).
81. Shafiee, M. A. et al. Defining conditions that lead to the retention of water: the importance of the arterial sodium concentration. Kidney Int. 67, 613-621 (2005). (Pubitemid 40139852)
82. Robertson, G. L. Abnormalities of thirst regulation. Kidney Int. 25, 460-469 (1984). (Pubitemid 14142836)
83. Zerbe, R. L., Miller, J. Z. & Robertson, G. L. The reproducibility and heritability of individual differences in osmoregulatory function in normal human subjects. J. Lab. Clin. Med. 117, 51-59 (1991).